Patients with HPV-positive oropharynx cancer should receive chemoradiation [ESMO 2018 Press Release]

Head and neck cancers - Cancer Immunology and Immunotherapy

Immunotherapy improves survival in metastatic or recurrent head and neck cancer [ESMO 2018 Press Release]

Head and neck cancers - Cancer Immunology and Immunotherapy

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer [ESMO 2018 Press Release]

Gastrointestinal cancers - Cancer Immunology and Immunotherapy

Immunotherapy may become new first line treatment in some metastatic colorectal cancers [ESMO 2018 Press Release]

Gastrointestinal

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma [ESMO 2018 Press Release]

Genitourinary

Local radiotherapy improves survival in metastatic prostate cancer with low disease burden [ESMO 2018 Press Release]

Genitourinary

Olaparib maintenance extends progression-free survival by estimated 3 years in advanced ovarian cancer [ESMO 2018 Press Release]

malignancies

Erlotinib improves progression-free survival in early mutated non-small cell lung cancer [ESMO 2018 Press Release]

Lung and other thoracic

Multi-strain probiotic reduces chemotherapy-induced diarrhoea [ESMO 2018 Press Release]

Palliative and supportive care

Drugs for treating breast cancer in women are effective and well tolerated in men [ESMO 2018 Press Release]

Breast cancer - Cancer in Special Situations / Population

Barriers to early clinical trial access for adolescents and young adults still exist, study shows [ESMO 2018 Press Release]

Cancer in Special Situations / Population - Personalised medicine

Targeting specific genomic mutation in breast cancer improves outcomes, first study shows [ESMO 2018 Press Release]

Breast cancer

New option for women with advanced breast cancer resistant to hormone therapy [ESMO 2018 Press Release]

Breast cancer

Some patients with metastatic triple negative breast cancer live longer with immunotherapy [ESMO 2018 Press Release]

Breast cancer

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer [ESMO 2018 Press Release]

Breast cancer

Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer [ESMO 2018 Press Release]

Breast cancer

Oncologists demand more education on the use of biosimilars: ESMO takes action [ESMO 2018 Press Release]

Anticancer agents & Biologic therapy

Immunotherapy is safe and feasible in cancer patients treated for HIV, study suggests [ESMO 2018 Press Release]

Pregnancy may be possible after chemotherapy for breast cancer patients – but many no longer wish to [ESMO 2018 Press Release]

Breast cancer - Cancer in Special Situations / Population

New research shows benefits of exercise for first time in advanced lung cancer [ESMO 2018 Press Release]

Regular exercise should be part of cancer care for all patients [ESMO 2018 Press Release]

Lung and other thoracic tumours

- Palliative and supportive care

Social vulnerability and medical skepticism top factors limiting adherence to cancer screening: an online survey [ESMO 2018 Press Release]

Diagnosis, Imaging and Staging - Epidemiology/Etiology/Cancer Prevention

Study indicates HER2+ early breast cancers where shorter-course trastuzumab could be an option [ESMO 2018 Press Release]

Breast cancer - Bioethics, legal and economic issues

Securing access to optimal cancer care through innovation, integration and sustainability [ESMO 2018 Press Release]

Huge variations between countries in time for reimbursement decisions on new cancer drugs [ESMO 2018 Press Release]

Bioethics, legal and economic issues

Women more prone to selected oesophagogastric cancer chemotherapy side-effects [ESMO 2018 Press Release]

Epidemiology/Etiology/Cancer Prevention - Personalised medicine

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy [ESMO 2018 Press Release]

Breast cancer